lol FDA is not going to do what some broker says - FDA will do as FDA will do ....
I do think 5051 will probably phase out Exondy's though given the drastic increase - that meetings Q3
FDA review re Sarepta 21/6/24 expanded gene therapy, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
